AVT06 (aflibercept biosimilar)

About Alvotech

Alvotech is a purpose-driven biosimilar company with a mission to improve lives by expanding global access to affordable biologic medicines. The company leverages a fully integrated platform from cell line development to commercial manufacturing to achieve speed and control. Its strategic pipeline includes several approved biosimilars, such as AVT02 (adalimumab), and a deep portfolio targeting major immunology and oncology drugs. Alvotech is publicly traded and partners with commercialization experts to bring its products to market worldwide.

Therapeutic Areas

Other Ophthalmology Drugs